Is The Viral 'Quad-demic' Still Swirling? Know The Good, Bad And Ugly

Updated Feb 7, 2025 | 01:00 AM IST

SummaryFlu, COVID-19, RSV, and norovirus are spreading at high levels in the U.S., causing overlapping symptoms like fever, fatigue, and nausea. Are early testing and vaccination enough to preventing severe infections with overlapping symptoms?
Is The Viral 'Quad-demic' Still Swirling? Know The Good, Bad And Ugly

Image Credit: Health and me

There's been an alarming increase of respiratory and gastrointestinal viruses in the United States lately, causing anxiety about a so-called "quad-demic". According to surveillance reports, influenza, COVID-19, RSV and norovirus are at very high levels everywhere. While the surge aligns with patterns typical for this season, several epidemiologists view simultaneous infections of such proportions to pose risks not only to individual healthcare but public health.

The incidence of the quad-demic should vary with seasonal patterns, vaccination rates, and public health interventions. Each virus alone is relatively easy to manage; however, the effect of all together could lead to overburdening of health care facilities and increase risks for those at higher risk. Continuing surveillance, early testing, and proactive prevention measures will play an important role in the control of these infections going forward.

While the term "quad-demic" sounds daunting, it must be taken into perspective. For years, we have had all these viruses together, and we have the capabilities to mitigate some of the risk. Vaccination, proper hygiene and using common sense helps individuals get through the season unscathed. Is the quad-demic a permanent fixture or just another seasonal wave? Let's break this down.

What is the Quad-demic?

Typically, flu, COVID-19, and RSV have been the primary culprits behind seasonal respiratory infections. However, norovirus, a highly contagious stomach bug, has emerged as a fourth significant player, inducing fears of a more severe and widespread viral outbreak. According to the Centers for Disease Control and Prevention (CDC), the U.S. recorded nearly 500 norovirus outbreaks between August and December 2023, a substantial rise from the previous year’s numbers.

While the term "quad-demic" may sound ominous, the seriousness and consequences of such infections should be weighed in light of the U.S. healthcare system's experience with managing viral surges since the start of the COVID-19 pandemic.

1. Influenza (Flu)

Flu continues to be one of the most common and alarming seasonal illnesses. In the period spanning from 2023 to 2024, there were approximately 40 million cases of flu, and thousands of hospitalizations along with reported 47 deaths have been reported this season. Flu symptoms include fever, chills, cough, sore throat, muscle pain, and fatigue, with most recovering within a week or two but risky factors for severe illness effects occur in young children, elderly, and people with chronic conditions.

2. Covid-19

Despite its reduction from the first pandemic peak, COVID-19 is still rampant. The CDC estimates that alone between October and December 2023, there were between 2.7 and 5 million cases in the U.S. Hospitalization has increased by cities such as Los Angeles, Chicago, and New York. Symptoms are closely similar to the flu, fever, cough, and fatigue but uniquely presents in some cases as loss of taste and smell.

3. RSV

RSV is the most common cause of lower respiratory infections in infants, older adults, and immunocompromised individuals. While RSV peaked late in 2023 and early 2024, it continues to be a threat because it can lead to bronchiolitis and pneumonia. It is very similar to the common cold, presenting with symptoms such as congestion, runny nose, coughing, and fever, which can make it difficult to differentiate from flu or COVID-19 without testing.

4. Norovirus

Norovirus, also called the "stomach flu," is a highly contagious infection of the gastrointestinal tract, not a respiratory virus. It transmits quickly from contaminated food and water and contact with contaminated surfaces, causing such symptoms as diarrhea, vomiting, nausea, and stomach pain. Cases have shot up, the CDC said Monday, with reports of outbreaks surging compared with last year.

Is There a Challenge In Diagnosis Due to Overlapping Symptoms?

The greatest challenge during the quad-demic is how the four viruses are alike and thus make identification very hard with no testing applied. Most cases present symptoms common to all viruses: fever, tiredness, body pains, and respiratory, which includes coughing and congestions for influenza, COVID-19, and RSV; the other would be norovirus symptoms as nausea and vomiting can appear even in extreme influenza and COVID-19. This overlap increases the risk of misdiagnosis and delayed treatment, hence the need for early testing and proper medical guidance.

Also Read: Is US Preparing For A Quad- demic 2025?

Effective Prevention Strategies That Work

The best defense against these viruses is a combination of vaccines, hygiene, and lifestyle precautions. While lifestyle modifications are highlighted as part of the constant need to eat healthy, ensure daily movement and drinking adequate amount of fluids. There is a sure short two preventive strategies that are effective:

Vaccination

  • Flu vaccine: Annual flu shots reduce the severity of infection, allergic flare ups and hospitalizations.
  • COVID-19 vaccine: Though COVID-19 cases have declined, vaccination remains critical in preventing severe outcomes.
  • RSV vaccine: Available for those aged 60 years and older, especially those with underlying conditions.
  • Norovirus vaccine: No vaccine is yet available, but mRNA vaccine research is in progress.

Hygiene and Sanitation

  • Washing hands frequently with soap and water for at least 20 seconds, especially after public exposure.
  • Disinfect frequently touched surfaces regularly, use sanitiser when outside.
  • Avoid close contact with infected people and wear masks.

Do You Need To Wear A Mask All The Time?

While debates on masked wear continue on, experts on mask-wear affirm that this does not only have a historical precedent but works towards reducing airborne viruses spreading within the environments. Hospitals, though, ensure masking in key sections of themselves. Publicized mask-wear remains a discretion, though massing indoors still goes a longer way in cases like peak flu seasons.

If you notice the symptoms of these viruses, then it's best to be confined at home and avoid having face-to-face interaction with others and seek immediate attention from your physician if your condition worsens. Quarantining for some days can decrease the spread of infection.

As we move into the first half of 2025 and beyond, staying informed and proactive is the best strategy for maintaining health and avoiding unnecessary panic. The key takeaway? Stay vigilant, but don’t be alarmed—these viruses are here, but so are the means to fight them.

End of Article

Bean-Based Chewing Gum Cuts HPV Levels By Up To 93%: Could It Help Prevent Cancer?

Updated Nov 17, 2026 | 12:00 AM IST

SummaryResearchers found that extracts of the bean-based gum reduced HPV levels by up to 93% in oral samples from patients with head and neck cancer.
Bean-Based Chewing Gum Cuts HPV Levels By Up To 93%: Could It Help Prevent Cancer?

Credit: iStock

Could chewing gum one day help fight cancer? Researchers at the University of Pennsylvania in the US have developed an experimental gum made from lablab beans, also known as Indian beans, that targets human papillomavirus (HPV) and harmful oral bacteria associated with head and neck cancer.

In laboratory tests using oral samples from cancer patients, extracts of the gum reduced HPV levels by up to 93%. An enhanced version also reduced two harmful bacterial species to nearly undetectable levels without affecting the beneficial bacteria tested.

How Does The Bean-Based Chewing Gum Work?

The experimental gum builds on the team's earlier research into lablab beans. It contains FRIL, a naturally occurring plant protein with antiviral properties.

Researchers tested gum extracts against microorganisms in oral samples collected from patients with head and neck cancer.

The results published in Scientific Reports journal showed:

  • HPV levels decreased by 93% in saliva samples.
  • HPV levels decreased by 80% in oral rinse samples.

The researchers also developed an enhanced version containing protegrin, an antimicrobial peptide. Peptides are short chains of amino acids, the building blocks of proteins.

A single dose of the enhanced gum extract reduced two targeted bacterial species, Porphyromonas gingivalis (Pg) and Fusobacterium nucleatum (Fn), to nearly undetectable levels.

Also read: HPV Vaccines Can Prevent Head And Neck Cancers In Men, Says Study

Harmful Bacteria Reduced Without Affecting Beneficial Microbes

The experimental formulation selectively targeted harmful bacteria while leaving the beneficial bacterial populations examined in the study largely unaffected.

The oral microbiome, which consists of microorganisms living inside the mouth, plays an important role in maintaining oral health.

Cancer treatments such as radiation therapy can disrupt this microbial balance, reducing beneficial bacteria and encouraging the growth of potentially harmful microorganisms, including Candida albicans, a type of yeast.

The researchers suggest that selectively targeting harmful microbes while preserving beneficial ones could be particularly useful for patients undergoing cancer treatment.

Read More: Russia's mRNA Cancer Vaccine: First Patient With Melanoma Completes Treatment, Shows No New Tumours

Could The Chewing Gum Help Prevent Cancer?

The researchers believe the findings warrant further investigation through human clinical trials. They envision the technology potentially being used alongside existing cancer treatments or as a preventive approach to limit infections.

"Lip and oral cavity cancer was the seventh leading cancer type in cancer incidence and mortality rate worldwide in adolescents, young adults, and middle-aged adults in 2022," Daniell said.

He said the findings support advancing these therapies into clinical trials as additional treatments or as prophylaxis to prevent infection and transmission.

Prophylaxis refers to measures taken to prevent a disease or infection before it occurs.

The plant-based technology could also offer a potentially affordable way to deliver protective proteins directly into the mouth.

However, the findings should be interpreted cautiously. The researchers tested gum extracts on patient samples under laboratory conditions. They have not established whether chewing the gum produces the same results in people or whether reducing these microorganisms can prevent cancer or improve treatment outcomes.

Human clinical trials will be needed to establish its safety and effectiveness. For now, the bean-based gum remains experimental and is not a proven cancer-prevention or treatment option.

End of Article

Antimicrobial Resistance Could Contribute To 39 Million Deaths By 2050: WHO

Updated Nov 16, 2026 | 10:00 PM IST

SummaryThe WHO warns that despite more countries adopting national AMR action plans, gaps in funding, infection prevention, laboratory capacity and surveillance are putting global 2030 targets at risk.
Antimicrobial Resistance Could Contribute To 39 Million Deaths By 2050: WHO

Credit: iStock

With one in six laboratory-confirmed bacterial infections worldwide already resistant to antibiotics, drug-resistant infections could contribute to more than 39 million deaths by 2050 if current trends persist, according to the World Health Organization (WHO).

Speaking at the virtual 6th Annual Global Media Forum on AMR, WHO officials warned that countries are not doing enough to tackle antimicrobial resistance (AMR), despite growing commitments. They also presented findings from the latest joint survey by WHO, the United Nations Environment Programme, the World Organisation for Animal Health and the Food and Agriculture Organization.

Although more countries have adopted national action plans to combat AMR, most have failed to translate these commitments into funded and implemented programmes. As a result, the world remains off track to meet key 2030 targets.

Of the 183 countries surveyed, 173 reported having a national action plan, up from 79 in 2017. However, only 42 said their plans were financed and implemented.

What Is Antimicrobial Resistance?

Also read: Over One In Four Americans Lied To Get Antibiotics For Children: Why It Can Be Dangerous

Antimicrobial resistance occurs when bacteria, viruses, fungi and parasites evolve and no longer respond to medicines designed to treat them. This makes infections harder to treat and increases the risk of disease spread, severe illness and death.

Antibiotic resistance is a form of AMR that specifically involves bacteria becoming resistant to antibiotics. Misuse and overuse of these medicines accelerate the problem.

At the 2024 United Nations General Assembly, countries agreed on a series of targets to tackle AMR by 2030. However, experts warn that the growing threat could undermine decades of medical progress.

"Procedures we now take for granted become far riskier when antibiotics and antimicrobials no longer work," Jean-Pierre Nyemazi, acting director of WHO's AMR department, said. The development of new antibiotics is also failing to keep pace with the spread of resistance, he added, Reuters reported.

"Unlike COVID-19, which was very visible, drug-resistant infections have been taking people's lives for years without us noticing it and raising the alarm as we should," Nyemazi said at the forum.

In 2021 alone, AMR was directly responsible for more than one million deaths and associated with approximately 4.7 million others, according to WHO figures.

What Did The WHO Survey Show?

The 2026 survey highlighted major gaps in infection prevention, a key measure for reducing the need for antibiotics.

The WHO reported that 128 countries now have national infection prevention and control programmes and guidelines, up from 90 in 2018. However, only 69 countries, or 38%, have implemented these programmes nationwide, well below the 2030 target of 90%.

Read More: 98 Years After Penicillin: Are We Running Out Of Effective Antibiotics?

Laboratory capacity also remains limited. While 131 countries reported having national reference laboratories capable of testing antibiotic resistance in common bacteria, only 66 could test for both bacterial and fungal resistance. Countries have agreed to ensure that 80% have these capabilities by 2030.

The WHO also released two toolkits to help countries strengthen diagnostic capacity, covering essential tests and laboratory procedures.

Surveillance has improved, with 113 countries now monitoring antibiotic use and 109 tracking antimicrobial resistance, compared with 65 and 39, respectively, in 2017.

However, only 21 countries reported integrating data on antibiotic use and resistance. The WHO said combining these datasets is essential to understand how antibiotic consumption drives resistance and to guide efforts to contain it.

Why Is Taking Unnecessary Antibiotics Dangerous?

Antibiotics treat bacterial infections but do not work against viral infections, which commonly cause cold- and flu-like symptoms. Unnecessary use can also expose patients to side effects and contribute to antimicrobial resistance.

As per the WHO, resistance exists across 22 different antibiotics—the common drugs used to treat everyday illnesses, such as:

  • Urinary tract infections (UTIs)
  • Stomach and intestinal infections
  • Dangerous blood infections
  • The sexually transmitted disease gonorrhoea

When bacteria develop resistance, infections become harder to treat, increasing the risk of complications and limiting available treatment options.

(With inputs from agencies)

End of Article

NASA Warns 2026 'Monster' El Niño Could Surpass 1997 Event: How It Could Affect Your Health

Updated Nov 16, 2026 | 07:00 PM IST

SummaryNASA scientists warn that the 2026–27 El Niño could rival or surpass the historic 1997–98 event. The potentially record-breaking climate phenomenon could intensify heatwaves, worsen air quality, alter infectious disease risks and increase food insecurity, raising concerns about its global public health impact.
NASA Warns 2026 'Monster' El Niño Could Surpass 1997 Event: How It Could Affect Your Health

Credit: iStock

NASA scientists warn that the developing 2026–27 El Niño could rival or surpass the powerful 1997–98 event, which triggered severe droughts, fires and flooding worldwide.

The new findings amid climate deliberations taking place at the COP31 in Turkiye.

Using 35 years of satellite observations, researchers are comparing the current event with previous strong El Niños. The climate phenomenon, marked by warmer-than-average sea-surface temperatures in the central and eastern equatorial Pacific, can disrupt weather patterns worldwide and raise global temperatures.

The 1997–98 and 2015–16 events were among the strongest on record, bringing fires to Indonesia and the Amazon, droughts in southern Africa, and heavy rainfall in Southern California.

How Does The 2026 El Niño Compare With The 1997 Event?

Also read: El Niño Could Worsen Dengue, Malaria And Heat Illness: Why WHO Declared A Health Emergency

Satellite altimetry measures changes in ocean surface height, helping scientists track heat accumulation in the Pacific. Warmer seawater expands, raising sea levels.

"What's unique about altimetry is that we have a 35-year record from nearly identical satellites flying almost the same ground track, with each mission overlapping the next," said Josh Willis, project scientist for sea level missions at NASA's Jet Propulsion Laboratory (JPL). "That lets us look back in time and compare this El Niño to what happened in 1997. And right now, this one is on track to be even bigger."

NASA's October measurements show similarities between the two events, including lower sea levels in the western Pacific, higher levels in the east and unusually warm water extending towards South America.

These patterns raise the possibility of similar weather effects, including substantial rainfall across California and the southern United States this winter.

Could The 2026–27 El Niño Become One Of The Strongest On Record?

Read More: Climate Crisis Is A Health Crisis: Just 6 Actions Could Save 1.6 Million Lives, Says WHO

NOAA's October 8 outlook estimated an 83% chance of strong to very strong El Niño conditions during the first three months of 2027.

On November 12, its Climate Prediction Center classified the event as "very strong", the highest of four intensity categories. Only three other events since 1950 have reached this level: 1982–83, 1997–98 and 2015–16.

However, El Niño's effects vary by region and do not guarantee the same weather extremes everywhere.

How Could The Super El Niño Affect Your Health?

The World Meteorological Organization (WMO) warns that El Niño could amplify climate change-related health risks, including:

  • Extreme heat: More intense heatwaves could increase heat-related illnesses and deaths.
  • Poor air quality: Wildfires could expose more people to smoke and pollution.
  • Infectious diseases: Changing weather patterns could alter the risk of dengue, malaria and cholera.
  • Food insecurity: Disrupted agriculture could worsen malnutrition and water shortages.
  • Extreme weather: Floods and storms could increase injuries, deaths and pressure on healthcare systems.

El Niño Could Push 49 Million More People Into Acute Hunger

A World Food Programme (WFP) analysis published in October projected that El Niño could push 49 million additional people into acute food insecurity by the end of 2027, taking the global total from 225 million to 274 million.

At least 45 countries could experience worsening food insecurity, particularly communities dependent on rain-fed agriculture. WFP warns that the effects could persist through 2027 and into early 2028.

End of Article